HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robertson, R. P. Articles by Takahashi, H. Search for Related Content PubMed PubMed Citation Articles by Robertson, R. P. Articles by Takahashi, H. Social Bookmarking                What's this?

Glucose Toxicity in ß-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection

From the Pacific Northwest Research Institute, Seattle, Washington

Chronic exposure to hyperglycemia can lead to cellular dysfunction that may become irreversible over time, a process that is termed glucose toxicity. Our perspective about glucose toxicity as it pertains to the pancreatic ß-cell is that the characteristic decreases in insulin synthesis and secretion are caused by decreased insulin gene expression. The responsible metabolic lesion appears to involve a posttranscriptional defect in pancreas duodenum homeobox-1 (PDX-1) mRNA maturation. PDX-1 is a critically important transcription factor for the insulin promoter, is absent in glucotoxic islets, and, when transfected into glucotoxic ß-cells, improves insulin promoter activity. Because reactive oxygen species are produced via oxidative phosphorylation during anaerobic glycolysis, via the Schiff reaction during glycation, via glucose autoxidation, and via hexosamine metabolism under supraphysiological glucose concentrations, we hypothesize that chronic oxidative stress is an important mechanism for glucose toxicity. Support for this hypothesis is found in the observations that high glucose concentrations increase intraislet peroxide levels, that islets contain very low levels of antioxidant enzyme activities, and that adenoviral overexpression of antioxidant enzymes in vitro in islets, as well as exogenous treatment with antioxidants in vivo in animals, protect the islet from the toxic effects of excessive glucose levels. Clinically, consideration of antioxidants as adjunct therapy in type 2 diabetes is warranted because of the many reports of elevated markers of oxidative stress in patients with this disease, which is characterized by imperfect management of glycemia, consequent chronic hyperglycemia, and relentless deterioration of ß-cell function.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Chen, G. Saxena, I. N. Mungrue, A. J. Lusis, and A. Shalev Thioredoxin-Interacting Protein: A Critical Link Between Glucose Toxicity and {beta}-Cell Apoptosis Diabetes, April 1, 2008; 57(4): 938 - 944. [Abstract] [Full Text] [PDF]

				D. K. Hagman, M. G. Latour, S. K. Chakrabarti, G. Fontes, J. Amyot, C. Tremblay, M. Semache, J. A. Lausier, V. Roskens, R. G. Mirmira, et al. Cyclical and Alternating Infusions of Glucose and Intralipid in Rats Inhibit Insulin Gene Expression and Pdx-1 Binding in Islets Diabetes, February 1, 2008; 57(2): 424 - 431. [Abstract] [Full Text] [PDF]

				P. Newsholme, E. P. Haber, S. M. Hirabara, E. L. O. Rebelato, J. Procopio, D. Morgan, H. C. Oliveira-Emilio, A. R. Carpinelli, and R. Curi Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity J. Physiol., August 15, 2007; 583(1): 9 - 24. [Abstract] [Full Text] [PDF]

				J. Pi, Y. Bai, Q. Zhang, V. Wong, L. M. Floering, K. Daniel, J. M. Reece, J. T. Deeney, M. E. Andersen, B. E. Corkey, et al. Reactive Oxygen Species as a Signal in Glucose-Stimulated Insulin Secretion Diabetes, July 1, 2007; 56(7): 1783 - 1791. [Abstract] [Full Text] [PDF]

				K. Kitiphongspattana, T. A. Khan, K. Ishii-Schrade, M. W. Roe, L. H. Philipson, and H. R. Gaskins Protective role for nitric oxide during the endoplasmic reticulum stress response in pancreatic beta-cells Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1543 - E1554. [Abstract] [Full Text] [PDF]

				L. Chen, H.-X. Yan, J. Chen, W. Yang, Q. Liu, B. Zhai, H.-F. Cao, S.-Q. Liu, M.-C. Wu, and H.-Y. Wang Negative Regulation of c-Myc Transcription by Pancreas Duodenum Homeobox-1 Endocrinology, May 1, 2007; 148(5): 2168 - 2180. [Abstract] [Full Text] [PDF]

				B. J. Goldstein Clinical Translation of "A Diabetes Outcome Progression Trial": ADOPT Appropriate Combination Oral Therapies in Type 2 Diabetes J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1226 - 1228. [Full Text] [PDF]

				B. L. Wajchenberg {beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment Endocr. Rev., April 1, 2007; 28(2): 187 - 218. [Abstract] [Full Text] [PDF]

				C. T. De Souza, E. P. Araujo, L. F. Stoppiglia, J. R. Pauli, E. Ropelle, S. A. Rocco, R. M. Marin, K. G. Franchini, J. B. Carvalheira, M. J. Saad, et al. Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action FASEB J, April 1, 2007; 21(4): 1153 - 1163. [Abstract] [Full Text] [PDF]

				M. J. Abrahamson A 74-Year-Old Woman With Diabetes JAMA, January 10, 2007; 297(2): 196 - 204. [Abstract] [Full Text] [PDF]

				L. Wang, S. Liu, A. D. Pradhan, J. E. Manson, J. E. Buring, J. M. Gaziano, and H. D. Sesso Plasma Lycopene, Other Carotenoids, and the Risk of Type 2 Diabetes in Women Am. J. Epidemiol., September 15, 2006; 164(6): 576 - 585. [Abstract] [Full Text] [PDF]

				G. R. Willsky, L.-H. Chi, Y. Liang, D. P. Gaile, Z. Hu, and D. C. Crans Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate Physiol Genomics, September 14, 2006; 26(3): 192 - 201. [Abstract] [Full Text] [PDF]

				M. S. Kirkman, R. R. Shankar, S. Shankar, C. Shen, E. Brizendine, A. Baron, and J. McGill Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the early diabetes intervention program. Diabetes Care, September 1, 2006; 29(9): 2095 - 2101. [Abstract] [Full Text] [PDF]

				S. Marshall Role of Insulin, Adipocyte Hormones, and Nutrient-Sensing Pathways in Regulating Fuel Metabolism and Energy Homeostasis: A Nutritional Perspective of Diabetes, Obesity, and Cancer Sci. Signal., August 1, 2006; 2006(346): re7 - re7. [Abstract] [Full Text] [PDF]

				M. Z. Khaldi, H. Elouil, Y. Guiot, J. C. Henquin, and J. C. Jonas Antioxidants N-acetyl-L-cysteine and manganese(III)tetrakis (4-benzoic acid)porphyrin do not prevent beta-cell dysfunction in rat islets cultured in high glucose for 1 wk Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E137 - E146. [Abstract] [Full Text] [PDF]

				E. Oh and D. C. Thurmond The Stimulus-induced Tyrosine Phosphorylation of Munc18c Facilitates Vesicle Exocytosis J. Biol. Chem., June 30, 2006; 281(26): 17624 - 17634. [Abstract] [Full Text] [PDF]

				C. Le May, K. Chu, M. Hu, C. S. Ortega, E. R. Simpson, K. S. Korach, M.-J. Tsai, and F. Mauvais-Jarvis Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice PNAS, June 13, 2006; 103(24): 9232 - 9237. [Abstract] [Full Text] [PDF]

				A. H. Barnett, M. Dreyer, P. Lange, M. Serdarevic-Pehar, and on behalf of the Exubera Phase III Study Group An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea. Diabetes Care, June 1, 2006; 29(6): 1282 - 1287. [Abstract] [Full Text] [PDF]

				G. Sesti, E. Laratta, M. Cardellini, F. Andreozzi, S. Del Guerra, C. Irace, A. Gnasso, M. Grupillo, R. Lauro, M. L. Hribal, et al. The E23K Variant of KCNJ11 Encoding the Pancreatic {beta}-Cell Adenosine 5'-Triphosphate-Sensitive Potassium Channel Subunit Kir6.2 Is Associated with an Increased Risk of Secondary Failure to Sulfonylurea in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2334 - 2339. [Abstract] [Full Text] [PDF]

				P. Pennisi, O. Gavrilova, J. Setser-Portas, W. Jou, S. Santopietro, D. Clemmons, S. Yakar, and D. LeRoith Recombinant Human Insulin-Like Growth Factor-I Treatment Inhibits Gluconeogenesis in a Transgenic Mouse Model of Type 2 Diabetes Mellitus Endocrinology, June 1, 2006; 147(6): 2619 - 2630. [Abstract] [Full Text] [PDF]

				D.-H. Lee, D. Y. Liu, D. R. Jacobs Jr., H.-R. Shin, K. Song, I.-K. Lee, B. Kim, and R. C. Hider Common Presence of Non-Transferrin-Bound Iron Among Patients With Type 2 Diabetes Diabetes Care, May 1, 2006; 29(5): 1090 - 1095. [Abstract] [Full Text] [PDF]

				J. Buteau, M. L. Spatz, and D. Accili Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic {beta}-Cell Mass. Diabetes, May 1, 2006; 55(5): 1190 - 1196. [Abstract] [Full Text] [PDF]

				L. Wang, S. Liu, J. E. Manson, J. M. Gaziano, J. E. Buring, and H. D. Sesso The Consumption of Lycopene and Tomato-Based Food Products Is Not Associated with the Risk of Type 2 Diabetes in Women J. Nutr., March 1, 2006; 136(3): 620 - 625. [Abstract] [Full Text] [PDF]

				R. Lupi, S. D. Guerra, M. Bugliani, U. Boggi, F. Mosca, S. Torri, S. D. Prato, and P. Marchetti The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets Eur. J. Endocrinol., February 1, 2006; 154(2): 355 - 361. [Abstract] [Full Text] [PDF]

				T. L Cuellar and M. T McManus MicroRNAs and endocrine biology J. Endocrinol., December 1, 2005; 187(3): 327 - 332. [Abstract] [Full Text] [PDF]

				L. Goth, Z. Toth, I. Tarnai, M. Berces, P. Torok, and W. N. Bigler Blood Catalase Activity in Gestational Diabetes Is Decreased but Not Associated with Pregnancy Complications Clin. Chem., December 1, 2005; 51(12): 2401 - 2404. [Full Text] [PDF]

				M. Cnop, N. Welsh, J.-C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik Mechanisms of Pancreatic {beta}-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities Diabetes, December 1, 2005; 54(suppl_2): S97 - S107. [Abstract] [Full Text] [PDF]

				Y. Song, J. E. Manson, J. E. Buring, H. D. Sesso, and S. Liu Associations of Dietary Flavonoids with Risk of Type 2 Diabetes, and Markers of Insulin Resistance and Systemic Inflammation in Women: A Prospective Study and Cross-Sectional Analysis J. Am. Coll. Nutr., October 1, 2005; 24(5): 376 - 384. [Abstract] [Full Text] [PDF]

				E. Sobngwi, J.-F. Gautier, J.-P. Kevorkian, J.-M. Villette, J.-P. Riveline, S. Zhang, P. Vexiau, S. M. Leal, C. Vaisse, and F. Mauvais-Jarvis High Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency without Gene Mutation Suggests a Novel Genetic Mechanism Predisposing to Ketosis-Prone Diabetes J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4446 - 4451. [Abstract] [Full Text] [PDF]

				M. C. Lawrence, K. McGlynn, B.-H. Park, and M. H. Cobb ERK1/2-dependent Activation of Transcription Factors Required for Acute and Chronic Effects of Glucose on the Insulin Gene Promoter J. Biol. Chem., July 22, 2005; 280(29): 26751 - 26759. [Abstract] [Full Text] [PDF]

				A. H. Minn, C. Hafele, and A. Shalev Thioredoxin-Interacting Protein Is Stimulated by Glucose through a Carbohydrate Response Element and Induces {beta}-Cell Apoptosis Endocrinology, May 1, 2005; 146(5): 2397 - 2405. [Abstract] [Full Text] [PDF]

				M. W. Fariss, C. B. Chan, M. Patel, B. Van Houten, and S. Orrenius ROLE of MITOCHONDRIA in TOXIC OXIDATIVE STRESS Mol. Interv., April 1, 2005; 5(2): 94 - 111. [Abstract] [Full Text] [PDF]

				H. Kaneto, Y. Nakatani, T. Miyatsuka, T.-a. Matsuoka, M. Matsuhisa, M. Hori, and Y. Yamasaki PDX-1/VP16 Fusion Protein, Together With NeuroD or Ngn3, Markedly Induces Insulin Gene Transcription and Ameliorates Glucose Tolerance Diabetes, April 1, 2005; 54(4): 1009 - 1022. [Abstract] [Full Text] [PDF]

				J. S. Harmon, R. Stein, and R. P. Robertson Oxidative Stress-mediated, Post-translational Loss of MafA Protein as a Contributing Mechanism to Loss of Insulin Gene Expression in Glucotoxic Beta Cells J. Biol. Chem., March 25, 2005; 280(12): 11107 - 11113. [Abstract] [Full Text] [PDF]

				S. Del Guerra, R. Lupi, L. Marselli, M. Masini, M. Bugliani, S. Sbrana, S. Torri, M. Pollera, U. Boggi, F. Mosca, et al. Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes Diabetes, March 1, 2005; 54(3): 727 - 735. [Abstract] [Full Text] [PDF]

				I. Rustenbeck, A. Wienbergen, C. Bleck, and A. Jorns Desensitization of Insulin Secretion by Depolarizing Insulin Secretagogues Diabetes, December 1, 2004; 53(suppl_3): S140 - S150. [Abstract] [Full Text] [PDF]

				D.-H. Lee, A. R Folsom, L. Harnack, B. Halliwell, and D. R Jacobs Jr Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1194 - 1200. [Abstract] [Full Text] [PDF]

				J. K. Young and J. C. McKenzie GLUT2 Immunoreactivity in Gomori-positive Astrocytes of the Hypothalamus J. Histochem. Cytochem., November 1, 2004; 52(11): 1519 - 1524. [Abstract] [Full Text] [PDF]

				P. Marchetti, S. Del Guerra, L. Marselli, R. Lupi, M. Masini, M. Pollera, M. Bugliani, U. Boggi, F. Vistoli, F. Mosca, et al. Pancreatic Islets from Type 2 Diabetic Patients Have Functional Defects and Increased Apoptosis That Are Ameliorated by Metformin J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5535 - 5541. [Abstract] [Full Text] [PDF]

				H. Zhao, S. Yakar, O. Gavrilova, H. Sun, Y. Zhang, H. Kim, J. Setser, W. Jou, and D. LeRoith Phloridzin Improves Hyperglycemia But Not Hepatic Insulin Resistance in a Transgenic Mouse Model of Type 2 Diabetes Diabetes, November 1, 2004; 53(11): 2901 - 2909. [Abstract] [Full Text] [PDF]

				R. Bottino, A.N. Balamurugan, H. Tse, C. Thirunavukkarasu, X. Ge, J. Profozich, M. Milton, A. Ziegenfuss, M. Trucco, and J. D. Piganelli Response of Human Islets to Isolation Stress and the Effect of Antioxidant Treatment Diabetes, October 1, 2004; 53(10): 2559 - 2568. [Abstract] [Full Text] [PDF]

				P. C. Moore, M. A. Ugas, D. K. Hagman, S. D. Parazzoli, and V. Poitout Evidence Against the Involvement of Oxidative Stress in Fatty Acid Inhibition of Insulin Secretion Diabetes, October 1, 2004; 53(10): 2610 - 2616. [Abstract] [Full Text] [PDF]

				V. Koshkin, G. Bikopoulos, C. B. Chan, and M. B. Wheeler The Characterization of Mitochondrial Permeability Transition in Clonal Pancreatic {beta}-Cells: MULTIPLE MODES AND REGULATION J. Biol. Chem., October 1, 2004; 279(40): 41368 - 41376. [Abstract] [Full Text] [PDF]

				T. P. Fleming, W. Y. Kwong, R. Porter, E. Ursell, I. Fesenko, A. Wilkins, D. J. Miller, A. J. Watkins, and J. J. Eckert The Embryo and Its Future Biol Reprod, October 1, 2004; 71(4): 1046 - 1054. [Abstract] [Full Text] [PDF]

				E. Gurgul, S. Lortz, M. Tiedge, A. Jorns, and S. Lenzen Mitochondrial Catalase Overexpression Protects Insulin-Producing Cells Against Toxicity of Reactive Oxygen Species and Proinflammatory Cytokines Diabetes, September 1, 2004; 53(9): 2271 - 2280. [Abstract] [Full Text] [PDF]

				L. E. Fridlyand and L. H. Philipson Does the Glucose-Dependent Insulin Secretion Mechanism Itself Cause Oxidative Stress in Pancreatic {beta}-Cells? Diabetes, August 1, 2004; 53(8): 1942 - 1948. [Abstract] [Full Text] [PDF]

				M. Z. Khaldi, Y. Guiot, P. Gilon, J. C. Henquin, and J. C. Jonas Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E207 - E217. [Abstract] [Full Text] [PDF]

				A. Ceriello and E. Motz Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 816 - 823. [Abstract] [Full Text]

				D. MELLOUL Transcription Factors in Islet Development and Physiology: Role of PDX-1 in Beta-Cell Function Ann. N.Y. Acad. Sci., April 1, 2004; 1014(1): 28 - 37. [Abstract] [Full Text] [PDF]

				Y. KAJIMOTO and H. KANETO Role of Oxidative Stress in Pancreatic {beta}-Cell Dysfunction Ann. N.Y. Acad. Sci., April 1, 2004; 1011(1): 168 - 176. [Abstract] [Full Text] [PDF]

				C. Tikellis, P. J. Wookey, R. Candido, S. Andrikopoulos, M. C. Thomas, and M. E. Cooper Improved Islet Morphology after Blockade of the Renin- Angiotensin System in the ZDF Rat Diabetes, April 1, 2004; 53(4): 989 - 997. [Abstract] [Full Text] [PDF]

				L. Wu, W. Nicholson, S. M. Knobel, R. J. Steffner, J. M. May, D. W. Piston, and A. C. Powers Oxidative Stress Is a Mediator of Glucose Toxicity in Insulin-secreting Pancreatic Islet Cell Lines J. Biol. Chem., March 26, 2004; 279(13): 12126 - 12134. [Abstract] [Full Text] [PDF]

				E. S. Nylen and B. Muller Endocrine Changes in Critical Illness J Intensive Care Med, March 1, 2004; 19(2): 67 - 82. [Abstract] [PDF]